What Is BPC-157? Research Overview of Body Protection Compound 157

Overview

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a partial sequence of human gastric juice protein BPC, which was identified in research investigating the gastroprotective properties of gastric secretions. The compound has been extensively studied in preclinical models due to its stability in biological environments and its broad range of observed effects across multiple tissue systems.

Chemical Identity

• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• Molecular formula: C₆₂H₉₈N₁₆O₂₂
• Molecular weight: ~1,419 Da
• CAS number: 137525-51-0
• Form: Typically supplied as a lyophilized white powder

BPC-157 is notable for its stability — unlike many peptides, it retains activity in acidic environments and is resistant to enzymatic degradation in gastric and intestinal fluids, which has contributed to its utility in oral administration studies in animal models.

Mechanism of Action

BPC-157 does not act through a single characterized receptor pathway. Proposed mechanisms from the preclinical literature include:

• Angiogenic signaling: Upregulation of VEGFR2 (vascular endothelial growth factor receptor 2) expression, promoting neovascularization in wound and repair models
• Nitric oxide (NO) system modulation: Interaction with the NO-signaling pathway, implicated in vascular tone and cytoprotection
• Growth hormone receptor sensitization: Preclinical data suggest BPC-157 may enhance tissue responsiveness to growth hormone signaling in musculoskeletal contexts
• Tendon and extracellular matrix effects: Upregulation of collagen synthesis markers and tendon fibroblast proliferation observed in in vitro and rodent models

Preclinical Research Areas

Published preclinical research has investigated BPC-157 across several biological systems:

• Gastrointestinal: Protection against NSAID-induced gastric lesions, esophageal and colonic injury models
• Musculoskeletal: Tendon-to-bone healing models, muscle injury repair, bone fracture studies in rodents
• Neurological: Dopamine and serotonin system interactions in rodent behavioral models; spinal cord injury studies
• Vascular: Anastomosis healing, peripheral vascular injury models

The majority of published studies are from Croatian research groups, with animal models predominantly in Sprague-Dawley rats. Human clinical trials are limited; researchers should evaluate the preclinical-to-clinical translation with appropriate scrutiny.

Research Specifications

• Purity: ≥98% by HPLC (research grade)
• Storage: −20°C lyophilized; reconstituted solutions at −80°C, avoid freeze-thaw
• Solubility: Soluble in sterile water, PBS, or dilute acetic acid
• COA should include HPLC trace, mass spectrometry confirmation, and endotoxin data

Important Disclaimer

BPC-157 is a research reagent. All content here is for scientific and educational purposes only. It is not approved for human or veterinary use, and is not a drug, supplement, or therapeutic product.